Vimarsana
Biggest News Aggregation in the World

Page 5 - Bymark Leiser News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bymark Leiser. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bymark Leiser Today - Breaking & Trending Today

FDA committee favors restricting prostate cancer regimen to BRCA -positive subgroup - Vimarsana News

FDA committee favors restricting prostate cancer regimen to BRCA -positive subgroup

An FDA advisory committee recommended that a proposed indication for olaparib with abiraterone acetate as first-line treatment for metastatic castration-resistant prostate cancer be limited to patients whose tumors have BRCA mutations.The Oncologic Drugs Advisory Committee voted 11 to 1 in favor of the restriction. One committee member abstained.

Source: healio.com
Adjuvant regimen has 'potential' to change practice in high-risk liver cancer - Vimarsana News

Adjuvant regimen has 'potential' to change practice in high-risk liver cancer

Adjuvant treatment with atezolizumab and bevacizumab extended RFS compared with active surveillance among patients with hepatocellular carcinoma, according to study findings presented at AACR Annual Meeting.The combination exhibited a generally manageable safety profile, results of the randomized phase 3 IMbrave050 trial showed.

Source: healio.com
Vaccine-immunotherapy combination extends RFS in high-risk melanoma - Vimarsana News

Vaccine-immunotherapy combination extends RFS in high-risk melanoma

The addition of an mRNA-based cancer vaccine to pembrolizumab extended RFS among patients with resected high-risk melanoma, according to study results presented at American Association for Cancer Research Annual Meeting.The benefit with the combination persisted regardless of patients’ tumor mutational burden status, findings of the randomized phase 2B KEYNOTE-942 trial showed.

Source: healio.com
Nab-paclitaxel regimen active in locally advanced cervical cancer - Vimarsana News

Nab-paclitaxel regimen active in locally advanced cervical cancer

The addition of nab-paclitaxel to cisplatin-based concurrent chemoradiotherapy appeared effective for women with locally advanced cervical cancer, according to prospective study results.The combination also appeared well tolerated, findings presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer showed.

Source: healio.com
Adjuvant nivolumab improves outcomes in high-risk urothelial cancer - Vimarsana News

Adjuvant nivolumab improves outcomes in high-risk urothelial cancer

SAN FRANCISCO — Adjuvant nivolumab improved outcomes compared with placebo for patients with high-risk muscle-invasive urothelial carcinoma, according to study results.Extended follow-up of the randomized phase 3 CheckMate 274 trial — presented at ASCO Genitourinary Cancers Symposium — showed the agent extended DFS, non–urothelial tract recurrence-free survival and distant

Source: healio.com